| 000 | 01543 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513190818.0 | ||
| 264 | 0 | _c19991012 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0730-2312 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeng, L | |
| 245 | 0 | 0 |
_aBcl-2 regulates chondrocyte morphology and aggrecan gene expression independent of caspase activation and full apoptosis. _h[electronic resource] |
| 260 |
_bJournal of cellular biochemistry _cSep 1999 |
||
| 300 |
_a576-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAggrecans |
| 650 | 0 | 4 |
_aAmino Acid Chloromethyl Ketones _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aChondrocytes _xcytology |
| 650 | 0 | 4 | _aCulture Media, Serum-Free |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 |
_aEnzyme Activation _xgenetics |
| 650 | 0 | 4 | _aExtracellular Matrix Proteins |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aGenes, bcl-2 |
| 650 | 0 | 4 | _aLectins, C-Type |
| 650 | 0 | 4 |
_aProteoglycans _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 |
_aRNA, Antisense _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aBalakir, R | |
| 700 | 1 | _aPrecht, P | |
| 700 | 1 | _aHorton, W E | |
| 773 | 0 |
_tJournal of cellular biochemistry _gvol. 74 _gno. 4 _gp. 576-86 |
|
| 999 |
_c10398681 _d10398681 |
||